Pulmonary arterial hypertension (PAH) is a devastating disease with an estimated median survival of less than 3 years when left untreated. The recent development of effective medical therapy has begun to transform this once rapidly lethal disease into a condition characterized by chronic, progressive respiratory impairment. As with other chronic respiratory conditions, the goals of therapy have broadened to include patient-oriented outcomes, specifically health-related quality-of-life. Unfortunately, very limited information exists on the utility of quality-of-life measures in PAH and how they relate to other more established clinical outcomes. Furthermore, little is known about how psychosocial factors may also mediate the effect of treatment on quality-of-life in PAH. The proposed research is designed to address these knowledge gaps using a mixed methods approach combining quantitative and qualitative research techniques. The quantitative component will build upon an existing prospective cohort study of patients treated for PAH. The qualitative component will consist of focus group sessions conducted among a subset of patients drawn from the larger cohort.
The specific aims are:
Aim 1 : To determine how quality-of-life relates to clinical measures of disease severity in PAH overtime;
Aim 2 : To determine if quality-of-life predicts health care utilization, lung transplant, and death in PAH;
and Aim 3 : To describe the impact of psychosocial factors on quality-of- life in patients with severe PAH. To insure the success of this multi-faceted study, an interdisciplinary team of researchers with expertise in pulmonary vascular disease, survey methods, psychometric analysis, health services research, and qualitative inquiry has been assembled. The proposed research is significant in that it utilizes a novel approach that will quantifiably establish quality-of-life as an important predictor and outcome in PAH, while also qualitatively informing a theoretical model that will assist in the development of future health status instruments. Such research is directly relevant to public health in that it will improve our ability to assess quality-of-life in PAH, thereby enabling us to identify those medical interventions that have the greatest impact on quality-of-life in this understudied population.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
5K23HL086585-04
Application #
7880642
Study Section
Special Emphasis Panel (ZHL1-CSR-R (M1))
Program Officer
Colombini-Hatch, Sandra
Project Start
2007-07-05
Project End
2012-06-30
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
4
Fiscal Year
2010
Total Cost
$152,820
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Singer, J P; Chen, J; Blanc, P D et al. (2013) A thematic analysis of quality of life in lung transplant: the existing evidence and implications for future directions. Am J Transplant 13:839-850
Roubinian, Nareg; Elliott, C Gregory; Barnett, Christopher F et al. (2012) Effects of commercial air travel on patients with pulmonary hypertension air travel and pulmonary hypertension. Chest 142:885-892
Chen, Hubert; Cisternas, Miriam G; Katz, Patricia P et al. (2011) Evaluating quality of life in patients with asthma and rhinitis: English adaptation of the rhinasthma questionnaire. Ann Allergy Asthma Immunol 106:110-118.e1
Singer, J P; Blanc, P D; Hoopes, C et al. (2011) The impact of pretransplant mechanical ventilation on short- and long-term survival after lung transplantation. Am J Transplant 11:2197-204
Katz, Patricia; Chen, Hubert; Omachi, Theodore A et al. (2011) The role of physical inactivity in increasing disability among older adults with obstructive airway disease. J Cardiopulm Rehabil Prev 31:193-7
Brown, Lynette M; Chen, Hubert; Halpern, Scott et al. (2011) Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry. Chest 140:19-26
Chen, H; De Marco, T; Kobashigawa, E A et al. (2011) Comparison of cardiac and pulmonary-specific quality-of-life measures in pulmonary arterial hypertension. Eur Respir J 38:608-16
Haselkorn, Tmirah; Chen, Hubert; Miller, Dave P et al. (2010) Asthma control and activity limitations: insights from the Real-world Evaluation of Asthma Control and Treatment (REACT) study. Ann Allergy Asthma Immunol 104:471-7
Chen, Hubert; Shiboski, Stephen C; Golden, Jeffrey A et al. (2009) Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension. Am J Respir Crit Care Med 180:468-74
Chen, Hubert; Taichman, Darren B; Doyle, Ramona L (2008) Health-related quality of life and patient-reported outcomes in pulmonary arterial hypertension. Proc Am Thorac Soc 5:623-30

Showing the most recent 10 out of 11 publications